{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:25:10Z","timestamp":1793262310696,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.yexmp.2007.02.008","type":"journal-article","created":{"date-parts":[[2007,3,27]],"date-time":"2007-03-27T11:16:30Z","timestamp":1174994190000},"page":"435-442","source":"Crossref","is-referenced-by-count":28,"title":["VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: Effects of statins"],"prefix":"10.1016","volume":"83","author":[{"given":"Thomas","family":"Anger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk K.","family":"Pohle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Barthel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan M.","family":"Ensminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodor","family":"Fischlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weyand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner G.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph D.","family":"Garlichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yexmp.2007.02.008_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.CIR.103.2.276","article-title":"An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro","volume":"103","author":"Aikawa","year":"2001","journal-title":"Circulation"},{"issue":"28","key":"10.1016\/j.yexmp.2007.02.008_bib2","doi-asserted-by":"crossref","first-page":"25032","DOI":"10.1074\/jbc.M204003200","article-title":"Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1","volume":"277","author":"Bavendiek","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.yexmp.2007.02.008_bib3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0735-1097(02)02496-8","article-title":"Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community","volume":"40","author":"Bellamy","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.yexmp.2007.02.008_bib4","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.yexmp.2007.02.008_bib5","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1161\/CIRCULATIONAHA.104.486738","article-title":"Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies","volume":"111","author":"Freeman","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yexmp.2007.02.008_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1586\/14779072.2.1.107","article-title":"Acquired aortic stenosis","volume":"2","author":"Freeman","year":"2004","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"2","key":"10.1016\/j.yexmp.2007.02.008_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20011022","article-title":"Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis","volume":"195","author":"Gerdes","year":"2002","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.yexmp.2007.02.008_bib8","first-page":"894","article-title":"Transcription factor Egr-1 in calcific aortic valve disease","volume":"13","author":"Ghazvini-Boroujerdi","year":"2004","journal-title":"J. Heart Valve Dis."},{"issue":"18","key":"10.1016\/j.yexmp.2007.02.008_bib9","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/01.CIR.102.18.2185","article-title":"Overexpression of Eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation","volume":"102","author":"Haley","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.yexmp.2007.02.008_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0003-4975(02)04312-6","article-title":"Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis","volume":"75","author":"Jian","year":"2003","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.yexmp.2007.02.008_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0021-9150(03)00284-3","article-title":"Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis","volume":"170","author":"Kaden","year":"2003","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.yexmp.2007.02.008_bib12","first-page":"560","article-title":"Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis","volume":"13","author":"Kaden","year":"2004","journal-title":"J. Heart Valve Dis."},{"issue":"2","key":"10.1016\/j.yexmp.2007.02.008_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00392-004-1021-0","article-title":"Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis","volume":"93","author":"Kaden","year":"2004","journal-title":"Z Kardiol."},{"issue":"2","key":"10.1016\/j.yexmp.2007.02.008_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.carpath.2005.01.002","article-title":"Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis","volume":"14","author":"Kaden","year":"2005","journal-title":"Cardiovasc. Pathol."},{"issue":"4","key":"10.1016\/j.yexmp.2007.02.008_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1526-0968.2003.00075.x","article-title":"Hypercholesterolemic valvulopathy: an aspect of malignant atherosclerosis","volume":"7","author":"Kawaguchi","year":"2003","journal-title":"Therap. Apher. Dial."},{"issue":"2","key":"10.1016\/j.yexmp.2007.02.008_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1067\/mtc.2000.106968","article-title":"Osteopontin expression and calcium content in human aortic valves","volume":"120","author":"Kennedy","year":"2000","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"4","key":"10.1016\/j.yexmp.2007.02.008_bib17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6917","key":"10.1016\/j.yexmp.2007.02.008_bib18","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.yexmp.2007.02.008_bib19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/oxfordjournals.eurheartj.a060602","article-title":"Factors associated with calcific aortic valve degeneration in the elderly","volume":"15","author":"Lindroos","year":"1994","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.yexmp.2007.02.008_bib20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI6993","article-title":"Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells","volume":"104","author":"Mach","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.yexmp.2007.02.008_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/(SICI)1096-9896(200005)191:1<54::AID-PATH568>3.0.CO;2-Y","article-title":"Expression of endothelial cell adhesion molecules on heart valves: up-regulation in degeneration as well as acute endocarditis","volume":"191","author":"Muller","year":"2000","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.yexmp.2007.02.008_bib22","first-page":"281","article-title":"Transforming growth factor-beta-induced transition of fibroblasts: a model for myofibroblast procurement in tissue valve engineering","volume":"13","author":"Narine","year":"2004","journal-title":"J. Heart Valve Dis."},{"issue":"8","key":"10.1016\/j.yexmp.2007.02.008_bib23","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.92.8.2163","article-title":"Osteopontin is expressed in human aortic valvular lesions","volume":"92","author":"O'Brien","year":"1995","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.yexmp.2007.02.008_bib24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ahj.2003.12.014","article-title":"Aortic stenosis and hyperlipidemia: establishing a cause\u2013effect relationship","volume":"147","author":"Otto","year":"2004","journal-title":"Am. Heart J."},{"issue":"3","key":"10.1016\/j.yexmp.2007.02.008_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ehj.2003.12.010","article-title":"Aortic stenosis: even mild disease is significant","volume":"25","author":"Otto","year":"2004","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.yexmp.2007.02.008_bib26","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.95.9.2262","article-title":"Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome","volume":"95","author":"Otto","year":"1997","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.yexmp.2007.02.008_bib27","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1161\/01.CIR.101.21.2497","article-title":"New insights into the progression of aortic stenosis: implications for secondary prevention","volume":"101","author":"Palta","year":"2000","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.yexmp.2007.02.008_bib28","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.4065\/79.10.1242","article-title":"Association of cardiovascular risk factors to aortic valve calcification as quantified by electron beam computed tomography","volume":"79","author":"Pohle","year":"2004","journal-title":"Mayo Clin. Proc."},{"issue":"22","key":"10.1016\/j.yexmp.2007.02.008_bib29","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1161\/01.CIR.0000017435.87463.72","article-title":"Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve","volume":"105","author":"Rajamannan","year":"2002","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.yexmp.2007.02.008_bib30","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.CIR.0000070591.21548.69","article-title":"Human aortic valve calcification is associated with an osteoblast phenotype","volume":"107","author":"Rajamannan","year":"2003","journal-title":"Circulation"},{"issue":"2 Pt 1","key":"10.1016\/j.yexmp.2007.02.008_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-8703(05)80024-9","article-title":"Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography","volume":"119","author":"Roger","year":"1990","journal-title":"Am. Heart J."},{"issue":"6","key":"10.1016\/j.yexmp.2007.02.008_bib32","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0002-9440(10)64501-4","article-title":"Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes","volume":"161","author":"Salmi","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.yexmp.2007.02.008_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0735-1097(01)01705-3","article-title":"Progression of human aortic valve stenosis is associated with tenascin-C expression","volume":"39","author":"Satta","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9312","key":"10.1016\/j.yexmp.2007.02.008_bib34","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0140-6736(02)08161-8","article-title":"HMG CoA reductase inhibitor (statin) and aortic valve calcium","volume":"359","author":"Shavelle","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.yexmp.2007.02.008_bib35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cardiores.2004.09.017","article-title":"Lysophosphatidylcholine posttranscriptionally inhibits interferon-gamma-induced IP-10, Mig and I-Tac expression in endothelial cells","volume":"65","author":"Sheikh","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.yexmp.2007.02.008_bib36","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/01.ATV.0000030360.72503.56","article-title":"Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol","volume":"22","author":"Sukhova","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol.\u00a0"},{"issue":"2","key":"10.1016\/j.yexmp.2007.02.008_bib37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1010-7940(00)00456-5","article-title":"Aortic valve replacement for the calcified ascending aorta in homozygous familial hypercholesterolemia","volume":"18","author":"Yasuda","year":"2000","journal-title":"Eur. J. Cardiothorac. Surg."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480007000172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480007000172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T18:44:20Z","timestamp":1556304260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480007000172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0014480007000172"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2007.02.008","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}